David02835: I agree that today's announcement was a tremendous positive development going forward. My beef yesterday was that I was tired of all the pre-clinical academic research agreements. We've been there and done that for years now, with not much to show for it. I wanted CYGX to concentrate on completing one thing...the full build out of their synDNA manufacturing facility and the completion of an FDA cGMP "seal of approval", so they can start selling a product and earning some income. I hope they have the financing in place to complete the job. And with the new guy in place who will devote his full effort to the task, it will free up others at CYGX to sell synDNA to the pharmaceutical industry. Their one module can make enough synDNA currently to satisfy all the testing that other companies or universities want to try. Build up the demand. If it is better and cheaper the demand will be there, and the profits will follow.